title: Bone marrow transplantation from donors other than HLA identical siblings. What have we learned from previous experiences?
authors.affiliation: BMT Unit, Hôpital Jean Minjoz, Besançon, France.
authors.forename: P
authors.initials: P
authors.lastname: Hervé
authors.forename: J Y
authors.initials: JY
authors.lastname: Cahn
authors.forename: P
authors.initials: P
authors.lastname: Tiberghien
authors.forename: E
authors.initials: E
authors.lastname: Racadot
authors.forename: E
authors.initials: E
authors.lastname: Plouvier
authors.forename: M
authors.initials: M
authors.lastname: Flesch
authors.forename: J
authors.initials: J
authors.lastname: Wijdenes
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006680:HLA Antigens; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000276:immunology / Q000601:surgery*
chemical_list: D006680:HLA Antigens